Dr. Nihar Mehta | Peddar Road Super Speciality Clinic

Principle Investigator from Jaslok Hospital for the assured us (Perioperative Antiplatelet therapy in patients with drug-eluting Stent undergoing noncardiac surgery) trial, which is a randomized controlled trial to evaluate the preoperative use of antiplatelet drugs in patients who have received drug eluting stents in the past. This trial is a 3 year trial which aims to enroll 2000 patients from 10 institutions in India and Korea. The principle investigator is Dr. S.J. Park from Asan Medical Centre, Seoul, South Korea.
Research Co-ordinator for the protect trial (Patient Related Outcomes With Endevour Versus Cypher Stenting Trial) since 2011. The protect trial is an ongoing randomized controlled phase 4 interventional trial with 8800 patients and approximately 200 hospitals, to evaluate whether the Endevour stent (Zotarolimus Eluting Stent) protects against late stent thrombosis resulting in less death and myocardial infarction at 5 years when compared with the Cypher stent (Sirolimus Eluting Stent).
Research Co-ordinator for the Bio Matrix Registry since 2011. The Bio Matrix registry is a multicenter post marketing registry with an objective to evaluate the 2 year clinical safety and efficacy outcomes in patients treated with Bio Matrix stent (Biolimus A9 drug eluting stent with a biodegradable coating).
Co-investigator for the Jaslok CTO Registry, a registry of approximately 150 cases of Chronic Total Occlusions in coronary artery disease for which percutaneous coronary intervention was performed. This is an ongoing registry of cases done from 2010 to 2016 with a clinical follow up of 1 year.
Co-investigator for the Jaslok Rotablation Registry, which is an ongoing registry of rotablation done to calcified lesions in coronary arteries from 2010 to 2016 at Jaslok hospital. It involves a clinical follow up of one year.
Co-investigator for the Jaslok FFR/IFR Trial, which is an ongoing trial of FFR using adenosine versus nikorandil for hyperemia and IFR in intermediate coronary artery lesions conducted in 2017 at Jaslok Hospital.

Research Projects

Patients Speak